Takeshi Yamamoto Selected Research

Takeshi Yamamoto Research Topics

Disease

32	Heart Failure 01/2022 - 02/2004
18	Type 2 Diabetes Mellitus (MODY) 01/2022 - 07/2006
17	Food Hypersensitivity (Food Allergy) 01/2021 - 06/2007
15	Myocardial Infarction 01/2022 - 06/2004
12	Ventricular Tachycardia 01/2022 - 06/2005
12	Cardiac Arrhythmias (Arrythmia) 01/2022 - 09/2005
10	Polymorphic catecholergic ventricular tachycardia 01/2019 - 09/2005
9	Body Weight (Weight, Body) 08/2022 - 01/2016
8	Colitis 01/2022 - 01/2010
8	Pulmonary Embolism 12/2015 - 10/2003
7	ST Elevation Myocardial Infarction 05/2022 - 04/2006
7	Hemorrhage 09/2021 - 10/2003
7	Inflammation (Inflammations) 01/2021 - 09/2007
7	Infections 04/2020 - 10/2009
7	Malignant Hyperthermia 01/2020 - 01/2002
6	Neoplasms (Cancer) 12/2021 - 11/2009
6	Aortic Dissection 11/2021 - 04/2005
6	Shock 10/2021 - 06/2004
5	Thrombosis (Thrombus) 01/2022 - 02/2011
5	Acute Coronary Syndrome 11/2021 - 07/2005
5	Fibrosis (Cirrhosis) 01/2021 - 09/2006
5	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 01/2021 - 06/2004
5	Diarrhea 01/2019 - 03/2002
5	Hypertension (High Blood Pressure) 01/2019 - 09/2007
4	Mitochondrial Diseases (Mitochondrial Disease) 01/2021 - 01/2016
4	Starvation 01/2019 - 01/2016
4	Cardiogenic Shock 06/2015 - 10/2003
4	Pulmonary Edema 09/2014 - 01/2006
3	Hypertrophy 07/2022 - 12/2018
3	Rectal Neoplasms (Rectal Cancer) 06/2022 - 12/2021
3	Proteinuria 12/2021 - 01/2010
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021 - 09/2007
3	Ischemia 10/2020 - 01/2012
3	Immune System Diseases (Immune Disorders) 01/2020 - 01/2014
3	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2020 - 01/2018
3	Ventricular Fibrillation 12/2019 - 06/2004
3	Diabetic Nephropathies (Diabetic Nephropathy) 01/2019 - 08/2008
3	Heart Diseases (Heart Disease) 10/2017 - 03/2002
3	Dyslipidemias (Dyslipidemia) 11/2016 - 07/2006
3	Fever (Fevers) 01/2016 - 10/2010
3	Renal Insufficiency (Renal Failure) 11/2013 - 08/2006
2	Dry Eye Syndromes (Dry Eye Syndrome) 01/2022 - 09/2014
2	Corneal Injuries 01/2022 - 09/2014

Drug/Important Bio-Agent (IBA)

31	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 01/2022 - 01/2002
10	Proteins (Proteins, Gene)FDA Link 08/2022 - 09/2005
9	Calmodulin (Calcium-Dependent Activator Protein)IBA 01/2021 - 04/2010
9	Pharmaceutical PreparationsIBA 01/2021 - 09/2002
8	Dantrolene (Dantrium)FDA LinkGeneric 01/2022 - 09/2002
7	Glucose (Dextrose)FDA LinkGeneric 10/2020 - 12/2016
6	Biomarkers (Surrogate Marker)IBA 12/2021 - 09/2007
5	empagliflozinIBA 01/2022 - 10/2018
5	Dextran SulfateIBA 09/2021 - 11/2014
5	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 01/2016
5	Adenosine Triphosphate (ATP)IBA 01/2021 - 11/2008
5	kakkon-toIBA 01/2020 - 01/2009
5	Messenger RNA (mRNA)IBA 01/2020 - 01/2013
5	LDL CholesterolIBA 11/2017 - 06/2007
4	SolutionsIBA 01/2022 - 03/2002
4	Sodium-Glucose Transport ProteinsIBA 01/2022 - 10/2018
4	Therapeutic UsesIBA 01/2022 - 01/2009
4	CytokinesIBA 01/2022 - 01/2006
4	CatecholaminesIBA 01/2022 - 01/2016
4	AntigensIBA 01/2021 - 04/2008
4	Triglycerides (Triacylglycerol)IBA 01/2021 - 07/2006
4	Insulin (Novolin)FDA Link 10/2020 - 07/2006
4	Amino Acids FDA Link 01/2020 - 11/2010
4	Epinephrine (Adrenaline)FDA LinkGeneric 01/2020 - 11/2010
4	EnzymesIBA 01/2020 - 09/2006
4	CreatinineIBA 10/2019 - 08/2006
4	oxidized low density lipoproteinIBA 11/2017 - 07/2006
4	CalciumIBA 12/2012 - 11/2008
4	Peptides (Polypeptides)IBA 09/2005 - 01/2002
3	Green Fluorescent ProteinsIBA 07/2022 - 01/2016
3	Hyaluronic Acid (Hyaluronan)IBA 01/2022 - 01/2008
3	Nicotine FDA Link 01/2022 - 01/2014
3	OxazoloneIBA 01/2022 - 01/2010
3	Cholinergic Agents (Cholinergics)IBA 01/2022 - 11/2008
3	Drinking WaterIBA 09/2021 - 01/2017
3	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2021 - 01/2016
3	Fatty Acids (Saturated Fatty Acids)IBA 01/2021 - 10/2017
3	Phospholipids (Phosphatides)FDA LinkGeneric 01/2021 - 04/2017
3	Sirolimus (Rapamycin)FDA Link 01/2021 - 01/2019
3	Glucagon (Glukagon)FDA Link 12/2019 - 01/2013
3	Liraglutide FDA Link 02/2019 - 12/2016
3	Brain Natriuretic Peptide (Natrecor)FDA Link 02/2019 - 08/2006
3	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2018 - 10/2003
3	InflammasomesIBA 05/2017 - 07/2010
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2016 - 06/2007
3	TroponinIBA 12/2015 - 07/2005
3	Neurotransmitter Agents (Neurotransmitter)IBA 01/2014 - 11/2008
2	Castor Oil (Oil, Castor)IBA 01/2022 - 09/2014
2	Methylene Blue (Methylthioninium Chloride)FDA Link 01/2022 - 09/2014

Therapy/Procedure

23	Therapeutics 05/2022 - 03/2002
7	Catheters 01/2022 - 10/2003
6	Percutaneous Coronary Intervention 03/2022 - 06/2006
6	Thrombectomy 01/2022 - 05/2004
4	Extracorporeal Membrane Oxygenation 10/2021 - 01/2006
3	Drug Therapy (Chemotherapy) 06/2022 - 01/2012
3	Mechanical Ventilators (Ventilator) 09/2021 - 01/2009
3	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 11/2016 - 06/2004